Group 1 - The core viewpoint of the news is that ICBC International successfully assisted Shenzhen Xunce Technology Co., Ltd. in its IPO on the Hong Kong Stock Exchange, highlighting the company's commitment to supporting fintech innovation and its strong market position in this sector [1] - The IPO involved the issuance of 22,500,000 shares at a price of HKD 48.00 per share, resulting in a total issuance scale of approximately USD 139 million before the exercise of the over-allotment option [1] - ICBC International's role as a joint bookrunner and lead underwriter demonstrates its professional capabilities and leadership in the fintech IPO market, having previously completed significant projects for other fintech companies since 2020 [1] Group 2 - Xunce Technology is a leading provider of real-time data infrastructure and analytical solutions in China, offering IT solutions that cover data infrastructure and analysis across various industries [2] - The company's core products are characterized by high speed, accuracy, and scalability, serving clients in asset management, financial services, urban management, manufacturing, and telecommunications [2] - According to revenue projections for 2024, Xunce Technology ranks first in the domestic asset management sector for real-time data infrastructure and analysis, and fourth in the overall market [2]

Core Viewpoint - Gehua Cable (600037.SH) announced that Shenzhen Xunce Technology Co., Ltd. (stock code: 03317.HK), invested by Silk Road Golden Bridge Fund, will be listed on the main board of the Hong Kong Stock Exchange on December 30, 2025 [1] Group 1 - Xunce Technology will conduct a global offering of 22.5 million shares at a price of HKD 48 per share [1] - The shares to be listed are ordinary shares (H shares) [1] - After the global offering, Silk Road Golden Bridge Fund, as a limited partner, will indirectly hold approximately 3,326,563 shares of Xunce Technology, accounting for 1.03% of the total share capital post-issuance [1] Group 2 - The lock-up period for the shares held by Silk Road Golden Bridge Fund will be 12 months following the listing of Xunce Technology [1]

Group 1 - Hong Kong stocks showed strong performance in the afternoon, with semiconductor and robotics sectors leading the gains, as the Hang Seng Tech Index rose over 2% [1] - Notable stocks included Baidu Group-SW, which increased by over 8%, and Horizon Robotics, SMIC, and Hua Hong Semiconductor, which also led the gains [1] - The Hong Kong Tech ETF Tianhong (159128) recorded a trading volume exceeding 32 million HKD, with a net subscription of 28 million units during the session [1] Group 2 - Xunce Technology, known as the "first stock of large model Data Agent," officially listed today at a price of 48 HKD per share, with a market capitalization of 15.5 billion HKD [2] - The company has a significant shareholder in Guangxi Tencent Venture Capital, holding 5.59% of the issued ordinary shares [2] - Analysts from Galaxy Securities expect continued net inflows from foreign and southbound funds due to a favorable monetary policy environment, which may lead to substantial improvements in the profitability of Hong Kong-listed companies [2]

Core Viewpoint - On the penultimate trading day of 2025, the Hong Kong Stock Exchange witnessed a rare listing event with six new companies from various cutting-edge sectors going public, marking the first occurrence of six companies listing simultaneously since July 9 of the same year [1]. Group 1: Company Performances - The leading AI pharmaceutical company, Insilico Medicine, had a remarkable debut, with its stock price opening up by 45.53%, resulting in a profit of 5,475 HKD per lot, as its core Pharma.AI platform significantly reduces drug development cycles to nearly one-fourth of traditional methods [1]. - The digital twin technology company, Wuyi Vision, saw its stock rise by 14.75% at opening, focusing on building a "digital twin earth" and expanding real-time 3D technology applications beyond gaming [1]. - Meilian Holdings and Lin Qingxuan experienced stock increases of 15.63% and 9.3%, respectively, while Xunce and Woan Robotics opened nearly flat, with the former ranking first in the real-time data market for asset management and the latter being the retail sales champion in global home robotics systems [1]. Group 2: Stock Price Movements - Insilico Medicine: 35,000 HKD, +45.53% [2] - Meilian Holdings: 8.210 HKD, +15.63% [2] - Wuyi Vision: 35.000 HKD, +14.75% [2] - Lin Qingxuan: 85.000 HKD, +9.30% [2] - Woan Robotics: 73.800 HKD, 0.00% [2]

Group 1 - The core viewpoint of the article is that Xunce (03317) has successfully listed its shares at a price of HKD 48 per share, raising approximately HKD 966 million through the issuance of 22.5 million shares [1] - As of the report, Xunce's share price increased slightly to HKD 48.02, with a trading volume of HKD 37.23 million [1] - Xunce is identified as a provider of real-time data infrastructure and analytical solutions in China, offering IT solutions that encompass data infrastructure and data analysis for enterprises across various industries [1] Group 2 - The market value of China's real-time data infrastructure and analysis market is projected to reach RMB 18.7 billion in 2024, accounting for 4.5% of the total data infrastructure and analysis market in China [1] - Xunce ranks fourth in this segment by revenue, holding a market share of 3.4% [1] - In the asset management sector, which constitutes 11.2% of the real-time data infrastructure and analysis market in China, Xunce is the leading company with a market share of 11.6% as of 2024 [1]

Core Viewpoint - Xunce (03317) has officially listed its shares at a price of HKD 48 per share, raising approximately HKD 966 million through the issuance of 22.5 million shares [1] Company Overview - Xunce is a provider of real-time data infrastructure and analytical solutions in China, offering IT solutions that encompass data infrastructure and data analysis for enterprises across various industries [1] - The company's system integration services enable seamless deployment within clients' environments, including self-managed cloud and on-premises systems [1] Market Position - By 2024, the market value of China's real-time data infrastructure and analysis market is projected to reach RMB 18.7 billion, accounting for 4.5% of the total data infrastructure and analysis market in China [1] - In terms of revenue, Xunce ranks fourth in this segment with a market share of 3.4% [1] - The asset management sector is expected to represent 11.2% of the total real-time data infrastructure and analysis market in China by 2024 [1] - Xunce holds the leading position in the real-time data infrastructure market within China's asset management industry, with a market share of 11.6% based on 2024 revenue [1]

Group 1 - The core viewpoint of the article is that Xunce (03317) has successfully listed its shares at a price of HKD 48 per share, raising approximately HKD 966 million through the issuance of 22.5 million shares [1] - As of the report, the stock price has slightly increased to HKD 48.02, with a trading volume of HKD 37.23 million [1] - Xunce is identified as a provider of real-time data infrastructure and analytical solutions in China, offering IT solutions that encompass data infrastructure and data analysis for enterprises across various industries [1] Group 2 - The market value of China's real-time data infrastructure and analysis market is projected to reach RMB 18.7 billion by 2024, accounting for 4.5% of the total data infrastructure and analysis market in China [1] - Xunce ranks fourth in this segment by revenue, holding a market share of 3.4% [1] - In the asset management sector, which constitutes 11.2% of the real-time data infrastructure and analysis market in China, Xunce is the leading company with a market share of 11.6% as of 2024 [1]

Group 1 - The company, Zhixun (03317), announced the results of its share allocation, with a global offering of approximately 22.5 million H-shares [1] - The share price for the global offering was set at HKD 48 per share, resulting in a net fundraising of HKD 966 million [1] - The Hong Kong public offering was oversubscribed by 7.24 times, while the international offering was oversubscribed by 3.1 times [1] Group 2 - The Hong Kong public offering accounted for 10% of the total shares, while the international offering made up 90% [1] - The shares are expected to commence trading on the Hong Kong Stock Exchange on December 30, 2025, at 9:00 AM [1]

其中，香港公开发售获7.24倍认购，国际发售获3.1倍认购。 迅策(03317)公布配发结果，公司全球发售约2250万股H股，香港公开发售占10%，国际发售占90%。每 股发售价48港元，全球发售净筹9.66亿港元。每手100股H股，预期股份将于2025年12月30日上午九时正 在联交所开始买卖。 ...

假设全球发售于2025年12月30日(星期二)上午八时正(香港时间)或之前成为无条件，则预期股份将于 2025年12月30日(星期二)上午九时正在联交所开始买卖。股份将以每手100股H股为买卖单位。H股的股 份代号将为3317。 格隆汇12月29日丨迅策(03317.HK)公告，公司全球发售22,500,000股H股，每股H股48.00港元，所得款 项净额9.66亿港元。香港公开发售股份数目占全球发售股份数目10%，获认购7.24倍；国际发售股份数 目占全球发售股份90%，获认购倍3.10倍。 ...